At Lindonlight, our goal is to bridge the gap between discovery and treatment in pediatric brain cancer.
These resources have been carefully selected to support those on the front lines of research and care, and we’ll continue to expand this list as new tools and opportunities emerge.
Due to the rarity of pediatric high-grade glioma, cell lines and PDX models are often difficult to access. However, these models are critical translational tools, enabling researchers to better understand disease mechanisms and test potential therapies in a controlled, reproducible environment.
Accurate glioma diagnosis depends on high-quality imaging and expert pathology review. These tools include diagnostic frameworks and in-depth lecture series that support more precise classification, guide clinical decision-making, and inform research.
Lindonlight 2450 Holcombe Boulevard Suite 2000 Houston, TX 77021
© Copyright 2025 Lindonlight. All right reserved.
